09.11.2011 • NewsPeopleAlbemarleCelanese

Albemarle Executive Chairman Mark Rohr to Take Over at Celanese

Celanese Chairman and CEO David N. Weidman will be retiring in April 2012.
Celanese Chairman and CEO David N. Weidman will be retiring in April 2012.

Celanese Chairman and CEO David N. Weidman will be retiring in April 2012. The company's board of directors has appointed Mark C. Rohr as his successor. Rohr is currently the executive chairman of Albemarle's board. He will step down from that position on Feb. 1.

Weidman joined Celanese in 2000. In 2002 he was named chief operating officer and was named chief executive officer in 2004 following the company's move from Germany to the United States. Weidman led the company through its initial public offering in January 2005 and was elected chairman of the board in 2007.

Company

Celanese

Brüningstr.
Frankfurt
Germany

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.